Journal of Clinical Pathways spoke with Anne C Chiang, MD, PhD, to better understand the Quality Oncology Practice Initiative.
To learn more about ACS CAN’s position and why opioid usage is such a hotly contested issue, Journal of Clinical Pathways spoke with Mark Fleury, PhD, MS, who is principal of Policy Development and Emerging Science at ACS CAN.
To gain an understanding of the data regarding HIFU and the appropriateness of its use in practice, the Journal of Clinical Pathways spoke with Jim C Hu, MD, MPH.
Ricky Newton, CPA, Community Oncology Alliance, speaks about how restricting physician dispensing can impact patient outcomes,.
Shelley Fuld Nasso speaks about the challenges cancer survivors continue to face and how clinical pathways can address the shortcomings of survivorship care.   
Jonathan Wilcox speaks on how a recent Institute for Clinical and Economic Review report and other value frameworks are affecting patient care.
Journal of Clinical Pathways spoke with Dr Christopher Lathan about the relationship between financial distress and cancer outcomes. 
Journal of Clinical Pathways spoke with Mark Boguski, MD, PhD, the co-founder and chief medical officer of Precision Medicine Network and a leading expert in precision medicine. 
Journal of Clinical Pathways spoke with Leonard Saltz, MD, chief of gastrointestinal oncology at Memorial Sloan Kettering Cancer Center, and Peter B Bach, MD, director at the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center, two health care professionals leading the conversation about unsustainable cost growth associated with cancer treatment.
Vikas Saini, MD discusses some of the issues facing the American health care system as well as what Right Care Alliance is trying to do to fix them.